Actimed Therapeutics Names Shaun Claydon As New Chief Financial Officer

Actimed Therapeutics Ltd, a UK-based clinical-stage pharmaceutical company focused on treating cancer cachexia and other muscle-wasting conditions, has appointed Shaun Claydon as its new Chief Financial Officer (CFO). Shaun brings more than 16 years of experience at the board level, mainly in the biotechnology sector. He is a Chartered Accountant and has held key financial roles in several healthcare companies. Notably, as CFO of Creabilis, a dermatology-focused pharma firm, he helped lead its $150 million sale to Sienna Biopharmaceuticals.

Robin Bhattacherjee, Actimed CEO, mentioned, “We are thrilled to welcome Shaun to the Actimed team. His broad industry experience and strong financial expertise will be invaluable as we continue to grow the company and advance our mission to bring innovation to the treatment of cachexia and muscle wasting conditions. Shaun's appointment complements and strengthens our leadership team at a critical time, and his contribution will help to ensure that Actimed is well positioned to meet its ambitious goals."

Shaun Claydon, Chief Financial Officer of Actimed, said in a statement, “I am excited to join Actimed at this important stage in the company’s journey. Actimed has an exciting future, is driven by a talented team, and possesses the capabilities to make a meaningful impact on the lives of patients suffering from muscle wasting conditions including cancer cachexia. I look forward to contributing to the company’s future development and to ensuring that we deploy our capital effectively and efficiently as we move forwards.”

He has also worked as CFO and COO at Orteq Sports Medicine, known for its biodegradable polymer technology, and served for six years as CFO of Destiny Pharma, a biotech company developing innovative anti-infective treatments. Earlier in his career, Shaun worked in financial consultancy and corporate finance at firms like PwC, Evolution Beeson Gregory (now part of Investec), and HSBC Investment Banking.